Tiago Girao - May 1, 2025 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Role: Chief Financial Officer
Signature: /s/ Christopher Van Tuyl, Attorney-in-Fact for Tiago Girao
Stock symbol: IMVT
Transactions as of: May 1, 2025
Transactions value $: $0
Form type: 4
Date filed: 5/5/2025, 07:30 PM
Previous filing: Apr 28, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Girao Tiago	Chief Financial Officer	C/O IMMUNOVANT, INC., 320 WEST 37TH STREET, 6TH FLOOR, NEW YORK	/s/ Christopher Van Tuyl, Attorney-in-Fact for Tiago Girao	2025-05-05	0001618670

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IMVT	Common Stock	Award	$0	+208K		$0.00	208K	May 1, 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IMVT	Stock Option (Right to Buy)	Award	$0	+294K		$0.00	294K	May 1, 2025	Common Stock	294K	$15.90	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan (the "Plan"). Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest as to 25% of the total shares on April 21, 2026 and the balance will vest in twelve (12) successive substantially equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date.
F2	These options were granted pursuant to the Plan. The shares underlying the options will vest as to 25% of the total shares on April 21, 2026 and the balance will vest in twelve (12) successive substantially equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date.

Content

These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan (the "Plan"). Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest as to 25% of the total shares on April 21, 2026 and the balance will vest in twelve (12) successive substantially equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date.

These options were granted pursuant to the Plan. The shares underlying the options will vest as to 25% of the total shares on April 21, 2026 and the balance will vest in twelve (12) successive substantially equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date.